AQR Arbitrage’s SeaStar Medical ICU Stock Holding History

AQR Arbitrage’s Portfolio ICU Stock Details ICU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-122	Closed	-$313K	–	1241
2022 Q3	$313K	Hold	122	–	–	0.01%	737
2022 Q2	$310K	Hold	122	–	–	0.01%	742
2022 Q1	$308K	Hold	122	–	–	0.01%	672
2021 Q4	$306K	Sell	122 -103	-46%	-$258K	0.01%	1034
2021 Q3	$564K	Buy	225 +10	+5%	+$24.8K	0.02%	596
2021 Q2	$532K	Buy	+215	New	+$532K	0.01%	594

Other funds holding ICU

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

CCFM

Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return

SWA

SFMG Wealth Advisors Plano, Texas $1.48B AUM 15.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AQR Arbitrage's ICU Position: Q4 2022 in Review

AQR Arbitrage sold out of SeaStar Medical (ICU) in Q4 2022, closing a stake of 122 shares — an estimated $313K sold.

AQR Arbitrage first reported a position in ICU in Q2 2021 and held it in 6 quarters. The position peaked at $564K in Q3 2021. 8 funds tracked by Wall St. Rank hold ICU as of Q4 2022.

AQR Arbitrage reported no remaining SeaStar Medical position as of Q4 2022 after selling out during the quarter.
AQR Arbitrage sold 122 SeaStar Medical shares in Q4 2022, an estimated $313K.
AQR Arbitrage first reported a position in SeaStar Medical in Q2 2021 and held it in 6 quarters.
AQR Arbitrage's SeaStar Medical position peaked at $564K in Q3 2021.
8 funds tracked by Wall St. Rank held SeaStar Medical as of Q4 2022.

Based on AQR Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.